These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18820)

  • 41. Conditioning regimens for marrow grafting.
    van Bekkum DW
    Semin Hematol; 1984 Apr; 21(2):81-90. PubMed ID: 6377501
    [No Abstract]   [Full Text] [Related]  

  • 42. In vivo and in vitro measurement of sensitization to rat marrow allografts.
    Klein DL; Bateman JL; Sepelak SB; Tutschka PJ; Elfenbein GJ; Santos GW
    Transplant Proc; 1978 Jun; 10(2):435-40. PubMed ID: 354134
    [No Abstract]   [Full Text] [Related]  

  • 43. Bone marrow transplantation in inbred strains of mice. I. The failure of development of normal T cell function following allogeneic transplantation.
    Trier L; Rubin B
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):724-32. PubMed ID: 4139875
    [No Abstract]   [Full Text] [Related]  

  • 44. Thalidomide induction of bone marrow transplantation tolerance.
    Vogelsang GB; Hess AD; Gordon G; Brundrette R; Santos GW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2658-61. PubMed ID: 3547944
    [No Abstract]   [Full Text] [Related]  

  • 45. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 46. Use of antithymocyte serum in clinical and experimental marrow transplantation.
    Storb R; Weiden PL; Thomas ED
    Postgrad Med J; 1976; 52(5 Suppl):96-103. PubMed ID: 11456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ifosfamide and ACNU in experimental allogeneic bone marrow transplantation.
    Gassmann W; Erbersdobler A; Uharek L; Glass B; Löffler H; Mueller-Ruchholtz W
    J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S224-7. PubMed ID: 1795012
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Graft-versus-Host reactions: a review.
    Grebe SC; Streilein JW
    Adv Immunol; 1976; 22():119-221. PubMed ID: 56872
    [No Abstract]   [Full Text] [Related]  

  • 49. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
    Rodt H; Therfelder S; Eulitz M
    Exp Hematol; 1974; 2(4):195-203. PubMed ID: 4156327
    [No Abstract]   [Full Text] [Related]  

  • 50. Sex-determined antigens in rats detected by bone marrow transplantation but not skin grafting.
    Dunn CD
    Transplantation; 1975 Aug; 20(2):142-9. PubMed ID: 1101479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The combined use of antilymphocyte serum and cyclophosphamide to suppress renal allograft rejection in the rat.
    Winearls CG; Fabre JW; Millard PR; Morris PJ
    Clin Exp Immunol; 1979 Feb; 35(2):242-9. PubMed ID: 373937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitigation of graft-versus-host disease in rats treated with allogeneic and xenogeneic antilymphocytic sera.
    Werner C; Ramirez E; Gervasoni C; Jeannet M
    Experientia; 1976 Feb; 32(2):241-2. PubMed ID: 5281
    [No Abstract]   [Full Text] [Related]  

  • 53. [Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia].
    Zwaan FE; Haak HL; van der Meer CW; Guiot HF; Hartgrink-Groeneveld CA; den Ottolander GJ; Willemze R; Eernisse JG; Brand A; van Rood JJ; Kunst MW; te Velde J; Noordwijk EM
    Ned Tijdschr Geneeskd; 1978 Mar; 122(10):326-32. PubMed ID: 24811
    [No Abstract]   [Full Text] [Related]  

  • 54. Of mice and men in bone marrow transplantation.
    Mathé G; Schwarzenberg L; Halle-Pannenko O; Abuaf N; Pouillart P
    Transplant Proc; 1977 Mar; 9(1):155-68. PubMed ID: 17189
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of effect of four cytotoxic agents on granulocytic and erythroid repopulating ability of rat bone marrow.
    Constable TB; Blackett NM
    J Natl Cancer Inst; 1972 Apr; 48(4):941-8. PubMed ID: 4554117
    [No Abstract]   [Full Text] [Related]  

  • 56. Marrow transplantation for the treatment of acute leukemia using HL-A-identical siblings.
    Buckner CD; Clift RA; Fefer A; Lerner KG; Neiman PE; Storb R; Thomas ED
    Transplant Proc; 1974 Dec; 6(4):365-6. PubMed ID: 4612892
    [No Abstract]   [Full Text] [Related]  

  • 57. The potential role of bone marrow transplantation in augmenting donor-derived immunity to hepatitis B after rat liver transplantation.
    Li J; Dahmen U; Dirsch OR; Gu Y; Polywka S; Fiedler M; Doebel L; Roggendorf M; Broelsch CE
    Liver Transpl; 2002 Apr; 8(4):397-404. PubMed ID: 11965586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Total lymphoid irradiation.
    Sutherland DE; Ferguson RM; Simmons RL; Kim TH; Slavin S; Najarian JS
    Urol Clin North Am; 1983 May; 10(2):277-88. PubMed ID: 6344387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Failure of early administration of antithymocyte globulin to lessen graft-versus-host disease in human allogeneic marrow transplant recipients.
    Doney KC; Weiden PL; Storb R; Thomas ED
    Transplantation; 1981 Feb; 31(2):141-3. PubMed ID: 7020176
    [No Abstract]   [Full Text] [Related]  

  • 60. [Letter: Lichen eruptions after allogenic bone marrow graft].
    Saurat JH; Gluckman E; Bussel A; Didier-Jean L
    Nouv Presse Med; 1975 Mar; 4(10):745 (1). PubMed ID: 236539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.